Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro

Anticancer Research

Volumn 31, Issue 1, 2011, Pages 33-38

  Koto, Masashi ^a   Cho, Heunglae ^b   Riesterer, Oliver ^c   Giri, Uma ^d   Story, Michael D ^e   Ha, Chul S ^f   Raju, Uma ^d  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inje University   (South Korea)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f San Antonio Cancer Institute   (United States)

Author keywords

Astrocytes; Central nervous system; Lymphoma; Radioprotection; Radiosensitivity

Indexed keywords

GLUTATHIONE;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL SURVIVAL; CELL VIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

APOPTOSIS; ASTROCYTES; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, RADIATION; GLUTATHIONE; HUMANS; LYMPHOMA, T-CELL; RADIATION TOLERANCE; TUMOR CELLS, CULTURED;

EID: 79851497271     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. DeAngelis LM, Gutin PH and Leibel SA: Intracranial Tumors. In: Diagnosis and Treatment. Martin Dunitz (ed.). London, UK, 2002.
2. Mohile NA and Abrey LE: Primary central nervous system lymphoma. Semin Radiat Oncol 17: 223-229, 2007. (Pubitemid 46963033)
3. Ferreri AJ, Abrey LE, Blay JY, Borisch B, Hochman J, Neuwelt EA, Yahalom J, Zucca E, Cavalli F, Armitage J and Batchelor T: Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Oncol 21: 2407-2414, 2003.
4. Cote TR, Manns A, Hardy CR, Yellin FJ and Hartge P: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 88: 675-679, 1996. (Pubitemid 26152554)
5. DeAngelis LM, Yahalom J, Thaler HT and Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635-643, 1992.
6. Chen MG, Prosnitz LR, Gonzalez-Serva A and Fischer DB: Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer 43: 1245-1254, 1979. (Pubitemid 9180290)
7. Fraser RW, Chism SE, Stern R, Fu KK and Buschke F: Clinical course of early extranodal non-Hodgkin's lymphomas. Int J Radiat Oncol Biol Phys 5: 177-183, 1979. (Pubitemid 9142169)
8. Horiuchi J, Okuyama T, Matsubara S, Shibuya H, Suzuki S and Kamiyama R: Extranodal non-Hodgkin's lymphoma in the head and neck. Irradiation and clinical course. Acta Radiol Oncol 21: 393-399, 1982.
9. Jacobs C and Hoppe RT: Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 11: 357-364, 1985.
10. Mill WB, Lee FA and Franssila KO: Radiation therapy treatment of stage I and II extranodal non-Hodgkin's lymphoma of the head and neck. Cancer 45: 653-661, 1980. (Pubitemid 10174603)
11. Shirato H, Tsujii H, Arimoto T, Miyamoto M, Azumi N, Nojima T, Watanabe S and Irie G: Early stage head and neck non-Hodgkin's lymphoma. The effect of tumor burden on prognosis. Cancer 58: 2312-2319, 1986.
12. Teshima T, Chatani M, Hata K, Inoue T, Miyahara H, Sato T, Shibata H, Kusakabe H, Tateishi R and Suzuki T: Radiation therapy for primary non-Hodgkin's lymphoma of the head and neck in stage I-II. Strahlenther Onkol 162: 478-483, 1986.
13. Wulfrank D, Speelman T, Pauwels C, Roels H and De Schryver A: Extranodal non-Hodgkin's lymphoma of the head and neck. Radiother Oncol 8: 199-207, 1987. (Pubitemid 17112898)
14. Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW and Murray KJ: Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23: 9-17, 1992.
15. Blay JY, Conroy T, Chevreau C, Thyss A, Quesnel N, Eghbali H, Bouabdallah R, Coiffier B, Wagner JP, Le Mevel A, Dramais-Marcel D, Baumelou E, Chauvin F and Biron P: High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16: 864-871, 1998. (Pubitemid 28108718)
16. Pollack IF, Lunsford LD, Flickinger JC and Dameshek HL: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63: 939-947, 1989. (Pubitemid 19063206)
17. Bessell EM, Lopez-Guillermo A, Villa S, Verger E, Nomdedeu B, Petit J, Byrne P, Montserrat E and Graus F: Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J Clin Oncol 20: 231-236, 2002.
18. Noel F and Tofilon PJ: Astrocytes protect against X-ray-induced neuronal toxicity in vitro. Neuroreport 9: 1133-1137, 1998. (Pubitemid 28266636)
19. Ehmann UK, Nagasawa H, Petersen DF and Lett JT: Symptoms of X-ray damage to radiosensitive mouse leukemic cells: asynchronous populations. Radiat Res 60: 453-472, 1974.
20. Green MH, Arlett CF, Cole J, Harcourt SA, Priestley A, Waugh AP, Stephens G, Beare DM, Brown NA and Shun-Shin GA: Comparative human cellular radiosensitivity: III. Gamma-radiation survival of cultured skin fibroblasts and resting T-lymphocytes from the peripheral blood of the same individual. Int J Radiat Biol 59: 749-765, 1991.
21. Hissin PJ and Hilf R: A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214-226, 1976.
22. Mirkovic N, Voehringer DW, Story MD, McConkey DJ, McDonnell TJ and Meyn RE: Resistance to radiation-induced apoptosis in Bcl-2 expressing cells is reversed by depleting cellular thiols. Oncogene 15: 1461-1470, 1997. (Pubitemid 27437836)
23. Cook JA, Gius D, Wink DA, Krishna MC, Russo A and Mitchell JB: Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol 14: 259-266, 2004. (Pubitemid 38903230)
24. Russo A, DeGraff W, Friedman N and Mitchell JB: Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res 46: 2845-2848, 1986. (Pubitemid 16074292)
25. Russo A, Mitchell JB, McPherson S and Friedman N: Alteration of bleomycin cytotoxicity by glutathione depletion or elevation. Int J Radiat Oncol Biol Phys 10: 1675-1678, 1984. (Pubitemid 14018277)
26. Brouazin-Jousseaume V, Guitton N, Legue F and Chenal C: GSH level and IL-6 production increased in Sertoli cells and astrocytes after gamma irradiation. Anticancer Res 22: 257-262, 2002. (Pubitemid 34475309)
27. Xu B, Kim ST, Lim DS and Kastan MB: Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 22: 1049-1059, 2002. (Pubitemid 34094842)
28. Dugan LL, Bruno VM, Amagasu SM and Giffard RG: Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci 15: 4545-4555, 1995.
29. Desagher S, Glowinski J and Premont J: Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 16: 2553-2562, 1996.
30. Brach MA, Gross HJ, Kaisho T, Asano Y, Hirano T and Herrmann F: Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B. J Biol Chem 265: 8466-8472, 1993. (Pubitemid 23118623)
31. Wolff SP, Garner A and Dean RT: Free radicals, lipids and protein degeneration. Trends Biochem Sci 11: 27-31, 1986. (Pubitemid 16184964)
32. Meister A and Anderson ME: Glutathione. Annu Rev Biochem 52: 711-760, 1983. (Pubitemid 13030692)
33. Vlachaki MT and Meyn RE: ASTRO research fellowship: the role of BCL-2 and glutathione in an antioxidant pathway to prevent radiation-induced apoptosis. Int J Radiat Oncol Biol Phys 42: 185-190, 1998. (Pubitemid 28435612)